BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will participate on a panel titled "Beyond Emerging Managers: Becoming an Established Manager" at the Emerging Managers 2009 Conference in Miami, FL
News | 04. 28. 2009
